Dr. Chris Paige

Vice President, Research
University Health Network

Dr. Paige earned a Ph.D. in Immunology at the Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences in 1979.  He became a Member of the Basel Institute for Immunology in Switzerland where he worked from 1980-1987 before joining the Ontario Cancer Institute as a Senior Scientist in 1987.  In 1990, Dr. Paige became the founding Director of the Arthritis and Autoimmunity Research Centre as well as Director of Research at The Wellesley Hospital.  In 1998,  Dr. Paige returned to the Ontario Cancer Institute to assume the role of Vice-President, Research and, subsequently, he assumed his current position of Vice President, Research at the University Health Network which is comprised of the Toronto General, Toronto Western and Princess Margaret Cancer Centre.
Dr. Paige is a Professor in the Departments of Medical Biophysics and Immunology at the University of Toronto.  He is an active educator in the undergraduate, graduate and postgraduate programs of the University’s School of Medicine and is a sought after speaker at science and medical conferences worldwide.
Dr. Paige is an internationally recognized leader in the area of lymphocyte development and antibody formation.  He is the Principle Investigator in a Terry Fox Program Project on blood cell development and also holds grants from the Canadian Institutes of Health Research.  His original research is published in leading scientific journals.  He has served on the Research Advisory Boards of both the National Cancer Institute and the Arthritis Society of Canada.
Dr. Paige is the President and founder, along with colleagues from the Wellesley Research Institute, of GEMMA Biotechnology.  Its purpose is to discover and commercially develop biological response modifiers which influence the course of human disease.

Dr. Paige is also the Chairman of the Board of BioDiscovery Toronto (BDT).  BDT is a consortium of the Toronto academic hospitals of the University of Toronto whose mission is to promote biotechnology.  This group was successful in obtaining funding for a biotech incubator now called the Toronto Biotechnology Commercialization Centre (TBCC) located at MaRS. Dr. Paige is a member of the Boards of the TBCC, the Ontario Institute for Cancer Research, Research Canada, The Princess Margaret Hospital Foundation, the Arthritis and Autoimmune Research Centre Foundation and the Toronto General and Western Hospital Foundation.  He is the past Chair of the Council of Ontario Research Directors (CORD).